Many studies have characterized that IL-6, IL8, IL-18, and IL-10 were significantly elevated in DM-ILD and associated with disease activity and prognosis (Gono et al., 2010; Gono et al., 2014; Chen et al., 2018). This evidence concerns the gene IL6 and dermatomyositis.